ONO-2020
/ Ono Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
May 02, 2025
ONO-2020-02: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
(clinicaltrials.gov)
- P2 | N=240 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
March 28, 2025
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
(clinicaltrials.gov)
- P2 | N=90 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia
March 18, 2025
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
(clinicaltrials.gov)
- P2 | N=240 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • Alzheimer's Disease • CNS Disorders
January 31, 2025
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
(clinicaltrials.gov)
- P2 | N=90 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia
February 22, 2024
A Phase 1 Study of ONO-2020 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=132 | Completed | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Completed
Trial completion
October 02, 2023
A Phase 1 Study of ONO-2020 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=138 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Trial completion date: Aug 2023 ➔ Dec 2023 | Trial primary completion date: Aug 2023 ➔ Dec 2023
Trial completion date • Trial primary completion date
August 19, 2022
A Phase 1 Study of ONO-2020 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=138 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P1 trial
1 to 7
Of
7
Go to page
1